- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Codexis Inc (CDXS)
Track the Codexis share price today and view real-time CDXS share price data, including charts, technicals, and key financials. View the CDXS premarket stock price ahead of the market session or assess the after hours quote. Explore CDXS stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Codexis Stock Price Today?
The Codexis stock price today is 2.600.
What Is the Stock Symbol for Codexis?
The stock symbol for Codexis is ""CDXS.""
What Stock Exchange Does Codexis Trade On?
Codexis is listed and trades on the NASDAQ stock exchange.
Is Codexis a Good Stock to Buy?
Determining whether Codexis or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CDXS quote. (ISIN: US1920051067)
What Is the Codexis Stock Price Today?
The Codexis stock price today is 2.600.
What Is the Stock Symbol for Codexis?
The stock symbol for Codexis is ""CDXS.""
What Stock Exchange Does Codexis Trade On?
Codexis is listed and trades on the NASDAQ stock exchange.
Is Codexis a Good Stock to Buy?
Determining whether Codexis or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CDXS quote. (ISIN: US1920051067)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.502
2.600
52 wk Range
0.958
3.870
CDXS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.5022.600
52 wk Range
0.9583.870
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CDXS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
6.583
Upside
+153.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
- Form 13G Codexis For: 5 May
- Investing.com
- Form 13G Codexis For: 5 May
- Investing.com
- Form DEF 14A CODEXIS For: 28 April
- Investing.com
- Form 13G Codexis For: 14 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.583
(+153.20% Upside)
Codexis Inc SWOT Analysis
Enzymatic Revolution | Codexis pivots to RNAi therapeutics manufacturing, leveraging its ECO Synthesis platform to address critical challenges in drug production scalability and efficiency |
Market Opportunity | Explore the billion-dollar potential in the growing RNAi therapeutics market, where Codexis aims to revolutionize manufacturing processes with its innovative approach |
Financial Fortitude | Delve into Codexis's robust financial position, with $90.3 million in cash reserves providing runway until 2027, despite current negative EBITDA of -$45.78 million |
Analyst Outlook | Cantor Fitzgerald maintains a consistent $11.00 price target throughout 2024, reflecting cautious optimism about Codexis's potential in the RNAi manufacturing arena |
Codexis Inc Earnings Call Summary for Q1/2026
- Codexis Q1 2026 EPS of -$0.10 beat forecast of -$0.16; revenue rose 102.7% YoY to $15.2M, exceeding estimates; shares gained 1.5% after-hours
- Gross margins improved significantly to 71% from 55% YoY, driven by strategic shift to higher-margin products and Merck Technology Transfer Agreement
- Operating expenses declined with R&D down 11.6% to $11.4M and SG&A down 21% to $9.8M; net loss narrowed 58% to $8.7M from $20.7M in Q1 2025
- Company projects Q2 2026 revenue of $16.5M with sustained gross margin levels; current cash reserves expected to fund operations through end of 2027
Last Updated: 08/05/2026, 10:40 am
Read Full TranscriptEarnings
Latest Release
07/05/2026
EPS / Forecast
-0.10 / -0.16
Revenue / Forecast
15.2M / 14.79M
Compare CDXS to Peers and Sector
Metrics to compare | CDXS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCDXSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.4x | −3.9x | −0.5x | |
PEG Ratio | −0.12 | −0.01 | 0.00 | |
Price/Book | 5.5x | 1.7x | 2.6x | |
Price / LTM Sales | 3.0x | 5.6x | 3.1x | |
Upside (Analyst Target) | 171.2% | 128.3% | 52.5% | |
Fair Value Upside | Unlock | 0.3% | 6.0% | Unlock |
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Codexis (CDXS) Stock Price Today?
The Codexis stock price today is 2.600 USD.
What Stock Exchange Does Codexis Trade On?
Codexis is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Codexis?
The stock symbol for Codexis is "CDXS."
What Is the Codexis Market Cap?
As of today, Codexis market cap is 235.420M USD.
What Is Codexis's Earnings Per Share (TTM)?
The Codexis EPS (TTM) is -0.359.
When Is the Next Codexis Earnings Date?
Codexis will release its next earnings report on 30/07/2026.
From a Technical Analysis Perspective, Is CDXS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Codexis Stock Split?
Codexis has split 0 times.
How Many Employees Does Codexis Have?
Codexis has 146 employees.
What is the current trading status of Codexis (CDXS)?
As of 26/05/2026, Codexis (CDXS) is trading at a price of 2.600 USD, with a previous close of 2.490 USD. The stock has fluctuated within a day range of 2.502 USD to 2.600 USD, while its 52-week range spans from 0.958 USD to 3.870 USD.
What Is Codexis (CDXS) Price Target According to Analysts?
The average 12-month price target for Codexis is 6.583 USD, with a high estimate of 11 USD and a low estimate of 2 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +153.21% Upside potential.
What Is the CDXS Premarket Price?
CDXS's last pre-market stock price is 2.550 USD. The pre-market share volume is 3,600.000, and the stock has decreased by 0.060, or 2.410%.
What Is the CDXS After Hours Price?
CDXS's last after hours stock price is 2.650 USD, the stock has decreased by 0.050, or 1.920%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.